471 related articles for article (PubMed ID: 9884278)
1. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
Djamali A; Odorico JS
Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
[TBL] [Abstract][Full Text] [Related]
2. Contribution of Fas ligand to cardiac allograft rejection.
Seino K; Kayagaki N; Bashuda H; Okumura K; Yagita H
Int Immunol; 1996 Sep; 8(9):1347-54. PubMed ID: 8921411
[TBL] [Abstract][Full Text] [Related]
3. Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection.
Subbotin V; Sun H; Aitouche A; Salam A; Valdivia LA; Fung JJ; Starzl TE; Rao AS
Transplantation; 1999 May; 67(10):1295-300. PubMed ID: 10360580
[TBL] [Abstract][Full Text] [Related]
4. Crucial Fas-Fas ligand interaction in spontaneous acceptance of hepatic allografts in mice.
Uchiyama H; Kishihara K; Minagawa R; Hashimoto K; Sugimachi K; Nomoto K
Immunology; 2002 Apr; 105(4):450-7. PubMed ID: 11985665
[TBL] [Abstract][Full Text] [Related]
5. CD95 ligand expression on corneal epithelium and endothelium influences the fates of orthotopic and heterotopic corneal allografts in mice.
Osawa H; Maruyama K; Streilein JW
Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1908-15. PubMed ID: 15161857
[TBL] [Abstract][Full Text] [Related]
6. Renal tubular epithelial cell apoptosis by Fas-FasL-dependent self-injury can augment renal allograft injury.
Du C; Guan Q; Yin Z; Masterson M; Zhong R; Jevnikar AM
Transplant Proc; 2003 Nov; 35(7):2481-2. PubMed ID: 14611992
[TBL] [Abstract][Full Text] [Related]
7. FasL is important in costimulation blockade-resistant skin graft rejection.
Trambley J; Lin A; Elwood E; Bingaman AW; Lakkis F; Corbascio M; Pearson TC; Larsen CP
Transplantation; 2001 Feb; 71(4):537-43. PubMed ID: 11258433
[TBL] [Abstract][Full Text] [Related]
8. Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts.
Takeda Y; Gotoh M; Dono K; Nishihara M; Grochowiecki T; Kimura F; Yoshida T; Ohta Y; Ota H; Ohzato H; Umeshita K; Takeda T; Matsuura N; Sakon M; Kayagaki N; Yagita H; Okumura K; Miyasaka M; Monden M
Diabetologia; 1998 Mar; 41(3):315-21. PubMed ID: 9541172
[TBL] [Abstract][Full Text] [Related]
9. Critical role of Fas/Fas ligand interaction in CD28-independent pathway of allogeneic murine hepatocyte rejection.
Kawahara T; Kasai S; Yagita H; Sawa M; Kato K; Azuma M; Nakajima A; Okumura K; Futagawa S; Mito M
Hepatology; 1997 Oct; 26(4):944-8. PubMed ID: 9328317
[TBL] [Abstract][Full Text] [Related]
10. The role of the perforin and Fas pathways of cytotoxicity in skin graft rejection.
Selvaggi G; Ricordi C; Podack ER; Inverardi L
Transplantation; 1996 Dec; 62(12):1912-5. PubMed ID: 8990386
[TBL] [Abstract][Full Text] [Related]
11. Abnormal IgG galactosylation and arthritis in MRL-Fas(lpr) or MRL-FasL(gld) mice are under the control of the MRL genetic background.
Kuroda Y; Nakata M; Nose M; Kojima N; Mizuochi T
FEBS Lett; 2001 Oct; 507(2):210-4. PubMed ID: 11684100
[TBL] [Abstract][Full Text] [Related]
12. Alloantigen-driven T cell death mediated by Fas ligand and tumor necrosis factor-alpha is not essential for the induction of allograft acceptance.
Wagener ME; Konieczny BT; Dai Z; Ring GH; Lakkis FG
Transplantation; 2000 Jun; 69(11):2428-32. PubMed ID: 10868653
[TBL] [Abstract][Full Text] [Related]
13. CD4(+) T-cell-mediated mechanisms of corneal allograft rejection: role of Fas-induced apoptosis.
Hegde S; Beauregard C; Mayhew E; Niederkorn JY
Transplantation; 2005 Jan; 79(1):23-31. PubMed ID: 15714165
[TBL] [Abstract][Full Text] [Related]
14. Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand.
Huber S; Shi C; Budd RC
J Virol; 2002 Jul; 76(13):6487-94. PubMed ID: 12050361
[TBL] [Abstract][Full Text] [Related]
15. The critical role of Fas-Fas ligand interaction in donor-specific transfusion-induced tolerance to H-Y antigen.
Minagawa R; Okano S; Tomita Y; Kishihara K; Yamada H; Nomoto K; Shimada M; Maehara Y; Sugimachi K; Yoshikai Y; Nomoto K
Transplantation; 2004 Sep; 78(6):799-806. PubMed ID: 15385797
[TBL] [Abstract][Full Text] [Related]
16. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis.
Wahlsten JL; Gitchell HL; Chan CC; Wiggert B; Caspi RR
J Immunol; 2000 Nov; 165(10):5480-6. PubMed ID: 11067900
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions.
Davidson WF; Giese T; Fredrickson TN
J Exp Med; 1998 Jun; 187(11):1825-38. PubMed ID: 9607923
[TBL] [Abstract][Full Text] [Related]
18. Acute cardiac allograft rejection by directly cytotoxic CD4 T cells: parallel requirements for Fas and perforin.
Grazia TJ; Plenter RJ; Weber SM; Lepper HM; Victorino F; Zamora MR; Pietra BA; Gill RG
Transplantation; 2010 Jan; 89(1):33-9. PubMed ID: 20061916
[TBL] [Abstract][Full Text] [Related]
19. Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome.
Chu JL; Ramos P; Rosendorff A; Nikolić-Zugić J; Lacy E; Matsuzawa A; Elkon KB
J Exp Med; 1995 Jan; 181(1):393-8. PubMed ID: 7528774
[TBL] [Abstract][Full Text] [Related]
20. Induction of allograft tolerance in the absence of Fas-mediated apoptosis.
Li XC; Li Y; Dodge I; Wells AD; Zheng XX; Turka LA; Strom TB
J Immunol; 1999 Sep; 163(5):2500-7. PubMed ID: 10452986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
